Biological activity of CXCL8 forms generated by alternative cleavage of the signal peptide or by aminopeptidase-mediated truncation

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Mortier, Anneleen ^a   Berghmans, Nele ^a   Ronsse, Isabelle ^a   Grauwen, Karolien ^a   Stegen, Steve ^a   van Damme, Jo ^a   Proost, Paul ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; CALCIUM; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; HEPARIN; INTERLEUKIN 8; PLASMIN; SIGNAL PEPTIDE; IL8 PROTEIN, HUMAN; THROMBIN;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CALCIUM SIGNALING; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PEPTIDE SYNTHESIS; PROTEIN CLEAVAGE; PROTEIN FOLDING; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; ANIMAL; CELL CULTURE; CELL MOTION; CHEMISTRY; CYTOLOGY; DRUG EFFECT; FEMALE; METABOLISM; NEUTROPHIL; PHYSIOLOGY; PROTEIN BINDING;

MUS;

AMINOPEPTIDASES; ANIMALS; CALCIUM; CELL MOVEMENT; CELLS, CULTURED; FEMALE; FIBRINOLYSIN; HEPARIN; HUMANS; INTERLEUKIN-8; MICE; NEUTROPHILS; PROTEIN BINDING; PROTEIN SORTING SIGNALS; RECEPTORS, INTERLEUKIN-8A; RECEPTORS, INTERLEUKIN-8B; THROMBIN;

EID: 80052321311     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023913     Document Type: Article

References (32)

1. Rot A, von Andrian UH, (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22: 891-928.
2. Snyderman R, Pike MC, (1984) Chemoattractant receptors on phagocytic cells. Annu Rev Immunol 2: 257-281.
3. Le Y, Murphy PM, Wang JM, (2002) Formyl-peptide receptors revisited. Trends Immunol 23: 541-548.
4. Wuyts A, Proost P, Lenaerts JP, Ben Baruch A, Van Damme J, et al. (1998) Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78. Eur J Biochem 255: 67-73.
5. Wuyts A, Proost P, Van Damme J, (1998) Interleukin-8 and other CXC chemokines. In: Thomson AW, editors. The Cytokine Handbook London Academic press pp. 271-311.
6. Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, et al. (2009) The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 10: 101-108.
7. Segal AW, (2005) How neutrophils kill microbes. Annu Rev Immunol 23: 197-223.
8. Wartha F, Beiter K, Normark S, Henriques-Normark B, (2007) Neutrophil extracellular traps: casting the NET over pathogenesis. Curr Opin Microbiol 10: 52-56.
9. Papayannopoulos V, Zychlinsky A, (2009) NETs: a new strategy for using old weapons. Trends Immunol 30: 513-521.
10. Mortier A, Van Damme J, Proost P, (2008) Regulation of chemokine activity by posttranslational modification. Pharmacol Ther 120: 197-217.
11. Van Damme J, Rampart M, Conings R, Decock B, Van Osselaer N, et al. (1990) The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms. Eur J Immunol 20: 2113-2118.
12. Walz A, Dewald B, von Tscharner V, Baggiolini M, (1989) Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils. J Exp Med 170: 1745-1750.
13. Walz A, Baggiolini M, (1990) Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases. J Exp Med 171: 449-454.
14. Proost P, Loos T, Mortier A, Schutyser E, Gouwy M, et al. (2008) Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J Exp Med 205: 2085-2097.
15. Proost P, Mortier A, Loos T, Vandercappellen J, Gouwy M, et al. (2007) Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 binding and signaling and reduces lymphocyte and endothelial cell migration. Blood 110: 37-44.
16. Clark-Lewis I, Schumacher C, Baggiolini M, Moser B, (1991) Structure-activity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities. J Biol Chem 266: 23128-23134.
17. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G, (2000) Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96: 2673-2681.
18. Loos T, Opdenakker G, Van Damme J, Proost P, (2009) Citrullination of CXCL8 increases this chemokine's ability to mobilize neutrophils into the blood circulation. Haematologica 94: 1346-1353.
19. Schröder JM, Sticherling M, Henneicke HH, Preissner WC, Christophers E, (1990) IL-1 alpha or tumor necrosis factor-alpha stimulate release of three NAP-1/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts. J Immunol 144: 2223-2232.
20. Van Damme J, Van Beeumen J, Conings R, Decock B, Billiau A, (1989) Purification of granulocyte chemotactic peptide/interleukin-8 reveals N-terminal sequence heterogeneity similar to that of beta-thromboglobulin. Eur J Biochem 181: 337-344.
21. Yoshimura T, Robinson EA, Appella E, Matsushima K, Showalter SD, et al. (1989) Three forms of monocyte-derived neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the amino-terminal sequence. Mol Immunol 26: 87-93.
22. Hebert CA, Luscinskas FW, Kiely JM, Luis EA, Darbonne WC, et al. (1990) Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. J Immunol 145: 3033-3040.
23. Nakagawa H, Hatakeyama S, Ikesue A, Miyai H, (1991) Generation of interleukin-8 by plasmin from AVLPR-interleukin-8, the human fibroblast-derived neutrophil chemotactic factor. FEBS Lett 282: 412-414.
24. Gimbrone MA, Obin MS, Brock AF, Luis EA, Hass PE, et al. (1989) Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science 246: 1601-1603.
25. Schroder JM, Christophers E, (1989) Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells. J Immunol 142: 244-251.
26. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, et al. (1987) Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci U S A 84: 9233-9237.
27. Van den Steen PE, Wuyts A, Husson SJ, Proost P, Van Damme J, et al. (2003) Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur J Biochem 270: 3739-3749.
28. Hebert CA, Vitangcol RV, Baker JB, (1991) Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J Biol Chem 266: 18989-18994.
29. von Heijne G, (1983) Patterns of amino acids near signal-sequence cleavage sites. Eur J Biochem 133: 17-21.
30. Ben Baruch A, Bengali KM, Biragyn A, Johnston JJ, Wang JM, et al. (1995) Interleukin-8 receptor beta. The role of the carboxyl terminus in signal transduction. J Biol Chem 270: 9121-9128.
31. Loos T, Mortier A, Proost P, (2009) Chapter 1. Isolation, identification, and production of posttranslationally modified chemokines. Methods Enzymol 461: 3-29.
32. Mortier A, Loos T, Gouwy M, Ronsse I, Van Damme J, et al. (2010) Posttranslational modification of the NH2-terminal region of CXCL5 by proteases or peptidylarginine deiminases (PAD) differently affects its biological activity. J Biol Chem 285: 29750-29759.